Overall, our study elucidates the molecular mechanism by which GLUT3 modulates chemosensitivity in GBM through chemotherapeutic drug transport, furnishing a theoretical foundation for intracellular drug transport in GBM and a fresh perspective for its clinical management. This evidence concerns the gene SLC2A3 and glioblastoma.